Transparent research demanded on GM crop health impacts

A French professor of molecular biology, in the news in India due to a Supreme Court challenge to a new GM crop, says much greater transparency is needed to judge the safety of this technology.

Gilles-Eric Seralini says confidential biotechnology company data is nowhere near robust enough—in its duration or its protocol—to establish the long-term human safety of GM crops with pesticidal properties.

Full Story: Business Standard